A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass (GTI-1307)
The purpose of this study is to learn more about a study product that may prevent complications after complex cardiac surgery. The levels of Antithrombin III (AT-III), a naturally occurring blood thinner, can be too high or too low after people have complex cardiac surgery with cardiopulmonary bypass (CPB). CPB is used during cardiac surgery to keep blood flowing through the heart and lungs while the heart is being operated on. This study will determine if the study product helps maintain safe AT-III levels.
High-risk cardiac surgery requiring CPB
Includes but not limited to:
-Male or female age 18+
-In need of non-emergency cardiac surgery requiring CPB
-Not in need of a heart transplant
-No history of cardiac surgery
18 - 99
Healthy Volunteers Needed
Duration of Participation
About 7 weeks
Grifols Therapeutics, Inc.
You will be paid $25.00 after the Day 30 Visit